TITLE:
Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia

CONDITION:
Schizophrenia

INTERVENTION:
Olanzapine

SUMMARY:

      The purpose of the protocol is to evaluate the efficacy of olanzapine compared with
      Aripiprazole in patients with schizophrenia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Male or female inpatient or outpatients, ages 18-65

        Exclusion Criteria:

          -  Participation in a clinical trial of another drug including olanzapine or
             aripiprazole within 30 days prior to study entry (visit 1).

          -  Treatment with clozapine within the past 12 months.

          -  Have known uncorrected narrow-angle glaucoma.

          -  Have a diagnosis of Parkinson's disease, dementia or related disorder
      
